am watching RAD and would have to agree 100% on nasdaq listing being a waste right now . It happened to IHL who I was in but not at the moment and it did nothing for them - if anything it hurt them in the short term , though it coincided with the market downturn. RAD have plenty going for it , focus on trials and commercialisation and key partnerships, that’s what’s pivotal.
Ann: RAD201 HER2 nanobody demonstrates favourable tumor targeting, page-15
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
